Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06253104
Title field or adapter rule
{'original_value': 'Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:31.490243+00:00
Published At
2026-10-26T00:00:00+00:00
Record Updated At
2026-10-26
Source Retrieved At
2026-10-31T22:18:30.505196+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Heart Failure", "Muscle Atrophy", "Skeletal Muscle Atrophy", "Cardiogenic Shock"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-26", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT06253104"
protocolSection.identificationModule.officialTitle
"Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
null
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Heart Failure (protocolSection.conditionsModule.conditions)
  • Muscle Atrophy (protocolSection.conditionsModule.conditions)
  • Skeletal Muscle Atrophy (protocolSection.conditionsModule.conditions)
  • Cardiogenic Shock (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Study Cohort'], 'description': 'We will use a BodyMetrix Pro A-mode ultrasound device (BodyMetrix Pro, Intelametrix Inc., Livermore, CA) which is a lay imaging tool designed specifically to assess body composition. Images will be taken at two sites; the lateral thigh and bicep on the dominant side if able to identify, or else on the right side. On each visit, five images will be taken at each site (the lateral thigh and bicep). Participants will be measured 2-3 days from initiation in study, then 7 days after, and then weekly from the first measurement until time of advanced therapy, discharge, or death. This measurement sequence will then be repeated following advanced therapy up until discharge or death. Each measurement session will last about 20-30 minutes. This will be performed by the PI or members of the study team who have been trained by the research coordinator.', 'name': 'BodyMetrix Body Composition Ultrasound', 'type': 'DIAGNOSTIC_TEST'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.